Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-355718 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 18, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
557
Total Value
$368.55
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and Chief Scientific Officer | Common Stock | โ | Aug 15, 2026 | Exercise/Conversion | 238 | โ | โ | 8,076 | Direct | โ | View Details | |
President and Chief Scientific Officer | Common Stock | โ | Aug 17, 2026 | Sale | 81 | $4.55 | $368.55 | 7,995 | Direct | โ | View Details | |
President and Chief Scientific Officer | Restricted Stock Units | Derivative | Aug 15, 2026 | Exercise/Conversion | 140 | $0.00 | $0.00 | 282 | Direct | โ | View Details | |
President and Chief Scientific Officer | Restricted Stock Units | Derivative | Aug 15, 2026 | Exercise/Conversion | 98 | $0.00 | $0.00 | 585 | Direct | โ | View Details |